Reply  by Ascher, Enrico
Patients have described the appearance of new telangiectasias after
saphenous vein treatment, RFA, or stripping. We have connected
the appearance of such new telangiectasias to the small vessels
surrounding thrombosed, treated segments of the saphenous vein,
mostly large vein valve sinuses. Small vessel networks can also be
noted around thrombus inside the canal previously occupied by a
stripped saphenous vein. Rather than dismiss the findings of small
vessel networks noted after treatment of the saphenous vein, we
should investigate whether and when the presence of these chan-
nels has a clinical effect. The first step was to recognize the presence
of such small vessel networks.
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Regarding: Carotid endarterectomy in patients
with chronic renal insufficiency: A recent series of
184 cases
We read with interest the article by Ascher et al (J Vasc Surg
2005;41:24-9) about early outcome of 184 internal carotid artery
endarterectomy procedures in 166 patients with chronic renal
insufficiency (CRI). These patients with CRI (serum creatinine
level 1.5 mg/dL) accounted for 27% of all patients undergoing
endarterectomy, a proportion much higher than in our own expe-
rience of 4.6% based on the same criterion (146/3157 patients
during 1990 to 2002). We believe that the higher risk of postop-
erative death associated with severe CRI, as shown by Ascher et al,
should limit the indication for surgery, especially in asymptomatic
patients on dialysis. Many vascular surgeons have intuitively ap-
plied that restriction. However, as shown by Reil et al,1 the
neurologic risks associated with endarterectomy are similar in
patients with CRI and normal renal function. Rather, it is cardiac
complications that are the most serious threat for death in these
patients.
Regretfully, Ascher et al failed to give details about the five
deaths that occurred in their series. However, in the meeting
discussion accompanying the article, the authors stated that two
deaths were due to myocardial infarction, one due to multiple
organ failure triggered by an unknown cause, one due to broncho-
pulmonary aspiration (neurologic status not specified), and one
due to postoperative stroke. This stroke-related death shows that it
would have been useful to do a thorough analysis of mortality
rather than to speculate about the potential role of protamine or
hemodynamic disturbances observed after dialysis sessions.
The article and meeting discussion also revealed an ambiguity
towards cardiac work-up. In the article, the authors suggest that
rigorous cardiac assessment is necessary even in asymptomatic
patients. In the discussion, they argue against such work-up by
stressing the morbidity of “open heart” surgery. It is unclear why
they would rule out the possibility of treating coronary artery
lesions screened by percutaneous angioplasty.
Patients with CRI must be considered a high-risk group for
carotid endarterectomy because of mortality rather than stroke
risk. In this regard, they may be better candidates for carotid
stenting, like those patients with advanced heart disease included
in the SAPPHIRE study.2 Further study would be necessary to
demonstrate the safety and long-term efficacy of such an approach.
Until then, our approach is to be very conservative in recommend-
ing carotid endarterectomy for patients with CRI, especially the
asymptomatic cohort.
Laurent Chiche, MD
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Reply
Thank you for your comments regarding our paper concern-
ing carotid endarterectomy in patients with chronic renal insuffi-
ciency (CRI). We agree with you that a more thorough assessment
of the cause of death postcarotid endarterectomy in these patients
would have been of value. However, upon reviewing the medical
records of the patients who died postoperatively, we were unable to
uncover a common denominator. We did speculate about the role
of protamine and also the hemodynamic disturbances that may
occur during hemodialysis, because these are known facts associ-
ated with increased mortality.
It is our opinion that coronary bypass surgery in patients with
severe CRI should be limited because of the associated increased
mortality and morbidity. Whether percutaneous coronary artery
balloon angioplasty is of value to these patients remains to be
proven.
Also, we agree with your comments that carotid endarterec-
tomy should not be liberally used in asymptomatic patients with
severe CRI. It will be interesting to see whether carotid artery
balloon angioplasty and stenting would be of benefit for this
cohort of patients in the long-term.
We appreciate your taking the time to read our paper and ask
reasonable questions.
Enrico Ascher, MD
Maimonides Medical Center
Brooklyn, NY
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